Molecular docking reveals a novel binding site model for fentanyl at the μ-opioid receptor

Govindan Subramanian, M. Germana Paterlini, Philip S Portoghese, David M Ferguson

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

The ligand binding modes of a series of fentanyl derivatives are examined using a combination of conformational analysis and molecular docking to the μ-opioid receptor. Condensed-phase molecular dynamics simulations are applied to evaluate potential relationships between ligand conformation and fentanyl substitution and to generate probable 'bioactive' structures for the ligand series. Automated docking of the largely populated solution conformers identified a common binding site orientation that places the N-phenethyl group of fentanyl deep in a crevice between transmembrane (TM) helices II and III while the N-phenylpropanamide group projected toward a pocket formed by TM-III, -VI, and -VII domains. An analysis of the binding modes indicates the most potent fentanyl derivatives adopt an extended conformation both in solution and in the bound state, suggesting binding affinity may depend on the conformational preferences of the ligands. The results are consistent with ligand binding data derived from chimeric and mutant receptor studies as well as structure-activity relationship data reported on a wide range of fentanyl analogues. The binding site mode] is also compared to that of N- phenethylnormorphine. An overlay of the bound conformation of the opiate and cis-3-methylfentanyl shows the N-phenethyl groups occupy equivalent binding domains in the receptor. While the cationic amines of both ligand classes were found docked to an established anchor site (D149 in TM-III), no overlap was observed between the N-phenylpropanamide group and the remaining components of the opiate scaffold. The unique binding mode(s) proposed for the fentanyl series may, in part, explain the difficulties encountered in defining models of recognition at the μ-receptor and suggest opioid receptors may display multiple binding epitopes. Furthermore, the results provide new insight to the design of experiments aimed at understanding the structural basis to the differential selectivities of ligands at the μ-, δ- , and κ-opioid receptors.

Original languageEnglish (US)
Pages (from-to)381-391
Number of pages11
JournalJournal of Medicinal Chemistry
Volume43
Issue number3
DOIs
StatePublished - Feb 10 2000

Fingerprint

Opioid Receptors
Fentanyl
Binding Sites
Ligands
Opiate Alkaloids
Molecular Docking Simulation
Molecular Dynamics Simulation
Structure-Activity Relationship
Amines
Epitopes

Cite this

Molecular docking reveals a novel binding site model for fentanyl at the μ-opioid receptor. / Subramanian, Govindan; Paterlini, M. Germana; Portoghese, Philip S; Ferguson, David M.

In: Journal of Medicinal Chemistry, Vol. 43, No. 3, 10.02.2000, p. 381-391.

Research output: Contribution to journalArticle

@article{60d55c198ef94a31a4ff58f3e6895726,
title = "Molecular docking reveals a novel binding site model for fentanyl at the μ-opioid receptor",
abstract = "The ligand binding modes of a series of fentanyl derivatives are examined using a combination of conformational analysis and molecular docking to the μ-opioid receptor. Condensed-phase molecular dynamics simulations are applied to evaluate potential relationships between ligand conformation and fentanyl substitution and to generate probable 'bioactive' structures for the ligand series. Automated docking of the largely populated solution conformers identified a common binding site orientation that places the N-phenethyl group of fentanyl deep in a crevice between transmembrane (TM) helices II and III while the N-phenylpropanamide group projected toward a pocket formed by TM-III, -VI, and -VII domains. An analysis of the binding modes indicates the most potent fentanyl derivatives adopt an extended conformation both in solution and in the bound state, suggesting binding affinity may depend on the conformational preferences of the ligands. The results are consistent with ligand binding data derived from chimeric and mutant receptor studies as well as structure-activity relationship data reported on a wide range of fentanyl analogues. The binding site mode] is also compared to that of N- phenethylnormorphine. An overlay of the bound conformation of the opiate and cis-3-methylfentanyl shows the N-phenethyl groups occupy equivalent binding domains in the receptor. While the cationic amines of both ligand classes were found docked to an established anchor site (D149 in TM-III), no overlap was observed between the N-phenylpropanamide group and the remaining components of the opiate scaffold. The unique binding mode(s) proposed for the fentanyl series may, in part, explain the difficulties encountered in defining models of recognition at the μ-receptor and suggest opioid receptors may display multiple binding epitopes. Furthermore, the results provide new insight to the design of experiments aimed at understanding the structural basis to the differential selectivities of ligands at the μ-, δ- , and κ-opioid receptors.",
author = "Govindan Subramanian and Paterlini, {M. Germana} and Portoghese, {Philip S} and Ferguson, {David M}",
year = "2000",
month = "2",
day = "10",
doi = "10.1021/jm9903702",
language = "English (US)",
volume = "43",
pages = "381--391",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Molecular docking reveals a novel binding site model for fentanyl at the μ-opioid receptor

AU - Subramanian, Govindan

AU - Paterlini, M. Germana

AU - Portoghese, Philip S

AU - Ferguson, David M

PY - 2000/2/10

Y1 - 2000/2/10

N2 - The ligand binding modes of a series of fentanyl derivatives are examined using a combination of conformational analysis and molecular docking to the μ-opioid receptor. Condensed-phase molecular dynamics simulations are applied to evaluate potential relationships between ligand conformation and fentanyl substitution and to generate probable 'bioactive' structures for the ligand series. Automated docking of the largely populated solution conformers identified a common binding site orientation that places the N-phenethyl group of fentanyl deep in a crevice between transmembrane (TM) helices II and III while the N-phenylpropanamide group projected toward a pocket formed by TM-III, -VI, and -VII domains. An analysis of the binding modes indicates the most potent fentanyl derivatives adopt an extended conformation both in solution and in the bound state, suggesting binding affinity may depend on the conformational preferences of the ligands. The results are consistent with ligand binding data derived from chimeric and mutant receptor studies as well as structure-activity relationship data reported on a wide range of fentanyl analogues. The binding site mode] is also compared to that of N- phenethylnormorphine. An overlay of the bound conformation of the opiate and cis-3-methylfentanyl shows the N-phenethyl groups occupy equivalent binding domains in the receptor. While the cationic amines of both ligand classes were found docked to an established anchor site (D149 in TM-III), no overlap was observed between the N-phenylpropanamide group and the remaining components of the opiate scaffold. The unique binding mode(s) proposed for the fentanyl series may, in part, explain the difficulties encountered in defining models of recognition at the μ-receptor and suggest opioid receptors may display multiple binding epitopes. Furthermore, the results provide new insight to the design of experiments aimed at understanding the structural basis to the differential selectivities of ligands at the μ-, δ- , and κ-opioid receptors.

AB - The ligand binding modes of a series of fentanyl derivatives are examined using a combination of conformational analysis and molecular docking to the μ-opioid receptor. Condensed-phase molecular dynamics simulations are applied to evaluate potential relationships between ligand conformation and fentanyl substitution and to generate probable 'bioactive' structures for the ligand series. Automated docking of the largely populated solution conformers identified a common binding site orientation that places the N-phenethyl group of fentanyl deep in a crevice between transmembrane (TM) helices II and III while the N-phenylpropanamide group projected toward a pocket formed by TM-III, -VI, and -VII domains. An analysis of the binding modes indicates the most potent fentanyl derivatives adopt an extended conformation both in solution and in the bound state, suggesting binding affinity may depend on the conformational preferences of the ligands. The results are consistent with ligand binding data derived from chimeric and mutant receptor studies as well as structure-activity relationship data reported on a wide range of fentanyl analogues. The binding site mode] is also compared to that of N- phenethylnormorphine. An overlay of the bound conformation of the opiate and cis-3-methylfentanyl shows the N-phenethyl groups occupy equivalent binding domains in the receptor. While the cationic amines of both ligand classes were found docked to an established anchor site (D149 in TM-III), no overlap was observed between the N-phenylpropanamide group and the remaining components of the opiate scaffold. The unique binding mode(s) proposed for the fentanyl series may, in part, explain the difficulties encountered in defining models of recognition at the μ-receptor and suggest opioid receptors may display multiple binding epitopes. Furthermore, the results provide new insight to the design of experiments aimed at understanding the structural basis to the differential selectivities of ligands at the μ-, δ- , and κ-opioid receptors.

UR - http://www.scopus.com/inward/record.url?scp=0034628575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034628575&partnerID=8YFLogxK

U2 - 10.1021/jm9903702

DO - 10.1021/jm9903702

M3 - Article

VL - 43

SP - 381

EP - 391

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 3

ER -